Additional information: according to the information received, the recipient experienced sudden decrease in hearing ability both in the implanted and non-implanted ear, following one session of hyperbaric oxygen treatments (hbot), during which central nervous system oxygen toxicity occurred.In situ measurements performed prior and after hbot are stable and indicative of a functional device.The observed performance decrease seems to most likely attributable to device unrelated clinical reasons, namely a possible side effect of hbot.In addition, it was reported that the user will need further brain radiation that might require implant removal.However, no plans in this regard have been made yet.
|